Convergence Investment Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$864K Sell
12,026
-14,053
-54% -$1.08M 0.14% 192
2025
Q4
$2.07M Buy
26,079
+18,911
+264% +$1.49M 0.41% 76
2025
Q3
$540K Sell
7,168
-333
-4% -$22.8K 0.12% 200
2025
Q2
$517K Sell
7,501
-308
-4% -$20.2K 0.13% 189
2025
Q1
$529K Sell
7,809
-641
-8% -$38.4K 0.15% 191
2024
Q4
$379K Sell
8,450
-4,539
-35% -$255K 0.08% 201
2024
Q3
$817K Buy
12,989
+6,920
+114% +$404K 0.22% 142
2024
Q2
$358K Sell
6,069
-294
-5% -$18.4K 0.1% 198
2024
Q1
$507K Sell
6,363
-2,466
-28% -$188K 0.19% 131
2023
Q4
$697K Buy
8,829
+960
+12% +$68.3K 0.36% 84
2023
Q3
$549K Sell
7,869
-12,360
-61% -$876K 0.32% 86
2023
Q2
$1.4M Sell
20,229
-857
-4% -$61K 0.8% 45
2023
Q1
$1.57M Buy
21,086
+2,567
+14% +$215K 0.92% 34
2022
Q4
$1.73M Sell
18,519
-2,853
-13% -$275K 1.02% 26
2022
Q3
$2.04M Sell
21,372
-5,144
-19% -$509K 1.33% 18
2022
Q2
$2.46M Sell
26,516
-664
-2% -$64.8K 1.49% 10
2022
Q1
$2.75M Buy
27,180
+736
+3% +$77.3K 1.42% 14
2021
Q4
$2.73M Buy
26,444
+2,210
+9% +$204K 1.39% 13
2021
Q3
$2.06M Sell
24,234
-1,450
-6% -$121K 1.1% 21
2021
Q2
$2.14M Sell
25,684
-204
-0.8% -$16.7K 0.92% 32
2021
Q1
$1.95M Sell
25,888
-1,085
-4% -$79K 0.89% 39
2020
Q4
$1.84M Sell
26,973
-12,990
-33% -$845K 0.93% 32
2020
Q3
$2.33M Buy
39,963
+1,956
+5% +$122K 0.81% 31
2020
Q2
$2.47M Buy
38,007
+19,936
+110% +$1.26M 0.85% 30
2020
Q1
$1.07M Sell
18,071
-229
-1% -$15.3K 0.47% 66
2019
Q4
$1.36M Buy
18,300
+11,644
+175% +$818K 0.39% 86
2019
Q3
$420K Sell
6,656
-20,344
-75% -$1.21M 0.12% 183
2019
Q2
$1.47M Buy
27,000
+1,085
+4% +$58.4K 0.36% 110
2019
Q1
$1.4M Sell
25,915
-34,055
-57% -$2.1M 0.31% 126
2018
Q4
$3.93M Buy
59,970
+5,239
+10% +$391K 0.9% 21
2018
Q3
$4.31M Buy
54,731
+7,585
+16% +$542K 0.88% 21
2018
Q2
$3.03M Sell
47,146
-25,415
-35% -$1.67M 0.42% 94
2018
Q1
$4.51M Buy
72,561
+5,361
+8% +$385K 0.59% 38
2017
Q4
$4.87M Buy
67,200
+16,238
+32% +$1.18M 0.65% 25
2017
Q3
$4.14M Buy
50,962
+179
+0.4% +$14.2K 0.59% 39
2017
Q2
$4.09M Buy
50,783
+23,013
+83% +$1.82M 0.6% 31
2017
Q1
$2.18M Buy
27,770
+119
+0.4% +$9.5K 0.31% 125
2016
Q4
$2.18M Buy
27,651
+24,356
+739% +$1.97M 0.3% 127
2016
Q3
$293K Buy
3,295
+528
+19% +$49.8K 0.04% 304
2016
Q2
$265K Sell
2,767
-24
-0.9% -$2.39K 0.04% 297
2016
Q1
$289K Sell
2,791
-531
-16% -$51.6K 0.03% 312
2015
Q4
$325K Sell
3,322
-40,882
-92% -$4M 0.04% 300
2015
Q3
$4.26M Buy
44,204
+13,809
+45% +$1.45M 0.49% 61
2015
Q2
$3.19M Buy
30,395
+27,004
+796% +$2.76M 0.31% 113
2015
Q1
$350K Sell
3,391
-22,550
-87% -$2.28M 0.05% 322
2014
Q4
$2.5M Sell
25,941
-30,010
-54% -$2.64M 0.33% 113
2014
Q3
$4.45M Sell
55,951
-525
-0.9% -$41.4K 0.61% 32
2014
Q2
$4.26M Buy
56,476
+5,253
+10% +$397K 0.56% 33
2014
Q1
$3.83M Buy
51,223
+47,377
+1,232% +$3.35M 0.58% 33
2013
Q4
$275K Sell
3,846
-48
-1% -$3.08K 0.04% 322
2013
Q3
$221K Buy
3,894
+344
+10% +$20.5K 0.05% 276
2013
Q2
$203K Buy
+3,550
New +$206K 0.05% 294

Other funds holding CVS

Convergence Investment Partners's CVS Position: Q1 2026 in Review

Convergence Investment Partners reduced its CVS Health (CVS) stake by 54% in Q1 2026, selling an estimated $1.08M and leaving 12,026 shares worth $864K. The position accounts for 0.14% of the portfolio, ranked #192.

Convergence Investment Partners first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.87M in Q4 2017. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Convergence Investment Partners held 12,026 shares of CVS Health worth $864K as of Q1 2026.
  • Convergence Investment Partners sold 14,053 CVS Health shares in Q1 2026, an estimated $1.08M.
  • CVS Health made up 0.14% of Convergence Investment Partners's portfolio in Q1 2026, its #192 holding.
  • Convergence Investment Partners first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Convergence Investment Partners's CVS Health position peaked at $4.87M in Q4 2017.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Convergence Investment Partners's 13F filing for Q1 2026, filed 7 May 2026.